|
⚲
|
| Keyboard |
| Khan Najat
✚
|
|
|---|---|
| CIK # | 0002020969 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002020969] | |
| 4 | [0002020969] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Khan Najat | |
| Recursion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-03-09 | Sell | 28,298 | $3.35 | 94,798 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-02-17 | Tax withheld | 14,280 | $3.49 | 49,837 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-02-06 | Grant | 30,346 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-02-06 | Tax withheld | 10,364 | $3.98 | 41,249 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-02-06 | Grant | 1,673,546 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-12-22 | Sell | 124,403 | $4.41 | 548,617 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-11-17 | Tax withheld | 17,584 | $4.14 | 72,798 |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-11-05 | Grant | 169,851 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-11-05 | Grant | 84,925 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-08-18 | Sell | 36,599 | $5.52 | 202,026 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-08-15 | Tax withheld | 3,789 | $5.64 | 21,370 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-05-15 | Tax withheld | 3,796 | $4.25 | 16,133 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-02-03 | Grant | 210,113 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-02-03 | Tax withheld | 2,753 | $7.25 | 19,959 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-02-03 | Grant | 8,049 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-02-03 | Grant | 420,226 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2024-08-01 | Grant | 993,944 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-08-01 | Grant | 496,972 | $0.00 |